Cancan Zhou

3.2k total citations · 1 hit paper
78 papers, 2.5k citations indexed

About

Cancan Zhou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Cancan Zhou has authored 78 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 20 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Cancan Zhou's work include Pancreatic and Hepatic Oncology Research (12 papers), MicroRNA in disease regulation (10 papers) and Heavy Metal Exposure and Toxicity (9 papers). Cancan Zhou is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), MicroRNA in disease regulation (10 papers) and Heavy Metal Exposure and Toxicity (9 papers). Cancan Zhou collaborates with scholars based in China, United States and Canada. Cancan Zhou's co-authors include Qingyong Ma, Zhengdong Jiang, Weikun Qian, Xuqi Li, Liang Cheng, Wanxing Duan, Jiguang Ma, Ke Chen, Wansheng Chen and Bin Yan and has published in prestigious journals such as PLoS ONE, Stroke and Chemosphere.

In The Last Decade

Cancan Zhou

75 papers receiving 2.4k citations

Hit Papers

Natural product derived phytochemicals in managing acute ... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cancan Zhou China 32 1.2k 542 513 304 303 78 2.5k
Montserrat Rojo de la Vega United States 24 2.8k 2.4× 284 0.5× 601 1.2× 284 0.9× 156 0.5× 36 3.9k
Yuehui Wang China 28 1.3k 1.1× 161 0.3× 203 0.4× 203 0.7× 300 1.0× 62 2.7k
Hiromichi Wada Japan 42 2.3k 2.0× 340 0.6× 514 1.0× 311 1.0× 476 1.6× 162 5.3k
Shu‐Hui Juan Taiwan 28 1.1k 1.0× 167 0.3× 267 0.5× 171 0.6× 137 0.5× 64 2.3k
Li Chu China 33 1.4k 1.2× 656 1.2× 271 0.5× 219 0.7× 236 0.8× 189 3.5k
Being‐Sun Wung Taiwan 31 1.5k 1.3× 193 0.4× 239 0.5× 510 1.7× 220 0.7× 43 3.0k
Beshay N. Zordoky United States 31 890 0.8× 370 0.7× 193 0.4× 130 0.4× 169 0.6× 61 2.7k
Sreejayan Nair United States 33 1.2k 1.0× 180 0.3× 245 0.5× 232 0.8× 331 1.1× 76 2.8k
Colin J. Meyer United States 34 3.2k 2.7× 310 0.6× 268 0.5× 580 1.9× 371 1.2× 82 5.2k
Jihong Yao China 34 2.0k 1.7× 291 0.5× 936 1.8× 251 0.8× 353 1.2× 101 3.9k

Countries citing papers authored by Cancan Zhou

Since Specialization
Citations

This map shows the geographic impact of Cancan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cancan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cancan Zhou more than expected).

Fields of papers citing papers by Cancan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cancan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cancan Zhou. The network helps show where Cancan Zhou may publish in the future.

Co-authorship network of co-authors of Cancan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Cancan Zhou. A scholar is included among the top collaborators of Cancan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cancan Zhou. Cancan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Tianli, Xingjie Wang, Kai Deng, et al.. (2025). FSP1 reduces exogenous coenzyme Q10 and inhibits ferroptosis to alleviate intestinal ischemia–reperfusion injury. Journal of Advanced Research. 1 indexed citations
2.
Zhou, Cancan, Qiqi Wang, Jiantao Mo, et al.. (2025). Tobacco carcinogen NNK promotes pancreatic cancer proliferation via LINC00857/β-catenin. Tobacco Induced Diseases. 23(April). 1–9.
3.
Feng, Zhengyuan, Jiantao Mo, Jie Li, et al.. (2024). Pharmacological inhibition of SREBP1 suppresses pancreatic cancer growth via inducing GPX4-mediated ferroptosis. Cellular Signalling. 124. 111381–111381. 4 indexed citations
4.
Deng, Kai, et al.. (2024). Research landscape of abdominal adhesions from 2004 to 2023: A bibliometric analysis. Heliyon. 10(9). e30343–e30343. 1 indexed citations
5.
Ni, Chenxu, Yu Zhao, Hong Qian, et al.. (2023). Long survival in a pancreatic carcinoma patient with multi-organ toxicities after sintilimab treatment: A case report. Frontiers in Pharmacology. 14. 1121122–1121122. 1 indexed citations
6.
Deng, Jiu-Ling, et al.. (2023). Ursodeoxycholic acid alleviates sepsis-induced lung injury by blocking PANoptosis via STING pathway. International Immunopharmacology. 125(Pt B). 111161–111161. 42 indexed citations
7.
Wang, Zijun, Cancan Zhou, Tianli Shen, et al.. (2023). Visual Observation of Abdominal Adhesion Progression Based on an Optimized Mouse Model of Postoperative Abdominal Adhesions. Journal of Investigative Surgery. 36(1). 2225104–2225104. 7 indexed citations
8.
Zhang, Weifan, Weikun Qian, Mengyuan Gong, et al.. (2022). Mutant p53 driven-LINC00857, a protein scaffold between FOXM1 and deubiquitinase OTUB1, promotes the metastasis of pancreatic cancer. Cancer Letters. 552. 215976–215976. 29 indexed citations
9.
Shen, Tianli, Yunhua Wu, Xingjie Wang, et al.. (2022). Activating SIRT3 in peritoneal mesothelial cells alleviates postsurgical peritoneal adhesion formation by decreasing oxidative stress and inhibiting the NLRP3 inflammasome. Experimental & Molecular Medicine. 54(9). 1486–1501. 21 indexed citations
10.
Zhou, Cancan, et al.. (2022). Zinc supplementation ameliorates sorafenib-induced cognitive impairment through ROS/JNK signaling pathway. Biological Trace Element Research. 201(1). 324–337. 9 indexed citations
13.
Xu, Qinhong, Ying Xiao, Xuqi Li, et al.. (2020). Resveratrol Counteracts Hypoxia-Induced Gastric Cancer Invasion and EMT through Hedgehog Pathway Suppression. Anti-Cancer Agents in Medicinal Chemistry. 20(9). 1105–1114. 35 indexed citations
14.
Qian, Weikun, Lin Wang, Tao Qin, et al.. (2020). Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NFκB activation. Biomedicine & Pharmacotherapy. 127. 110116–110116. 35 indexed citations
15.
Zhang, Jie, Cancan Zhou, Guanglin Qiu, et al.. (2018). Long non-coding RNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma by targeting miR‑206. Oncology Reports. 40(6). 3625–3634. 30 indexed citations
16.
Cheng, Liang, Bin Yan, Ke Chen, et al.. (2018). Resveratrol‐Induced Downregulation of NAF‐1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways. Oxidative Medicine and Cellular Longevity. 2018(1). 9482018–9482018. 69 indexed citations
17.
Wei, Guangbing, Cancan Zhou, Qi Gao, et al.. (2018). Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma. Technology in Cancer Research & Treatment. 17. 1877032869–1877032869. 23 indexed citations
18.
Yan, Bin, Liang Cheng, Zhengdong Jiang, et al.. (2018). Resveratrol Inhibits ROS‐Promoted Activation and Glycolysis of Pancreatic Stellate Cells via Suppression of miR‐21. Oxidative Medicine and Cellular Longevity. 2018(1). 1346958–1346958. 61 indexed citations
19.
Wei, Guangbing, Yunhua Wu, Qi Gao, et al.. (2017). Effect of Emodin on Preventing Postoperative Intra‐Abdominal Adhesion Formation. Oxidative Medicine and Cellular Longevity. 2017(1). 1740317–1740317. 44 indexed citations
20.
Zhou, Cancan, Zhengdong Jiang, Ke Chen, et al.. (2016). Preventive Effects of the Intestine Function Recovery Decoction, a Traditional Chinese Medicine, on Postoperative Intra‐Abdominal Adhesion Formation in a Rat Model. Evidence-based Complementary and Alternative Medicine. 2016(1). 1621894–1621894. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026